Retinitis Pigmentosa Clinical Trials in Anaheim, CA

Retinitis Pigmentosa Clinical Trials in Anaheim, CA

View the best 10 retinitis pigmentosa medical studies in Anaheim, California. Access promising new therapies by applying to a Anaheim-based Retinitis Pigmentosa clinical trial.

Trials in Anaheim, California

Here are the top 5 medical studies for retinitis pigmentosa in Anaheim, California

Image of Retina Vitreous Associates Medical Group in Beverly Hills, United States.

RTx-015

Virus Therapy

Recruiting1 awardPhase 1
This trial will test the safety and effectiveness of RTx-015 in patients with retinitis pigmentosa. About 9 patients will receive a single injection of RTx-015 in one eye and
Image of Vitreo Retinal Associates in Gainesville, United States.

AAV5-RPGR

Gene Therapy

Recruiting2 awardsPhase 3
This trial tests a gene therapy for people with X-linked retinitis pigmentosa. It uses a harmless virus to deliver a healthy gene to eye cells, aiming to improve their function and slow down vision loss. Gene therapy targeting the RPE65 gene has shown promise in treating inherited retinal dystrophies, including retinitis pigmentosa.
Image of University of California - Davis, Department of Ophthalmology & Vision Science in Davis, United States.

N-acetylcysteine

Antioxidant

Recruiting1 awardPhase 3
This trial is testing if N-acetylcysteine (NAC) can help slow down vision loss in people with Retinitis Pigmentosa (RP). RP is a genetic condition that causes gradual vision loss. NAC reduces damage caused by too much oxygen around eye cells, potentially protecting vision. N-acetylcysteine (NAC) has been shown to reduce oxidative damage and increase cone function/survival in studies related to RP.
Image of Retina-Vitreous Associates Medical Group in Beverly Hills, United States.

CNS10-NPC

Stem Cell Therapy

Recruiting1 awardPhase 1
This trial is testing if introducing special cells into the eye is safe for patients with vision loss. The cells might help protect and support the existing nerve cells in the eye, potentially slowing down or stopping vision loss.
Image of University of Miami, Bascom Palmer Eye Institute in Miami, United States.

Ultevursen

Antisense Oligonucleotide

Recruiting0 awardsPhase 2 & 3
This trial tests a drug called ultevursen, which is injected into the eye, for patients with a specific genetic form of Retinitis Pigmentosa. The drug targets and modifies the genetic mutation causing their vision loss.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.